Jan 2026· Cardiovascular Therapeutics· Vol 2026· 0 citations· 46 references
Medicine
TL;DR
No single clinical, imaging, or hemodynamic measure reliably predicts early RHF, and existing scores perform variably on external validation, so management begins by addressing reversible causes and optimizing LVAD support.
Abstract
Early right heart failure (RHF) remains common after left ventricular assist device (LVAD) implantation and is associated with substantial morbidity and mortality. Definition and time window determine reported incidence and complicate risk‐model comparison. Established risk models perform differently across cohorts and device eras, and temporary support should be matched to the dominant physiology. LV unloading alters venous return, septal geometry, and right ventricular (RV) loading, whereas perioperative stress exposes limited RV reserve. No single clinical, imaging, or hemodynamic measure reliably predicts early RHF, and existing scores perform variably on external validation. Dynamic hemodynamic assessment adds information about RV reserve and warrants prospective threshold validation. Management begins by addressing reversible causes and optimizing LVAD support. When temporary mechanical support is required, RV‐specific bypass restores pulmonary forward flow, an oxygenated right atrial‐to‐pulmonary arterial RVAD adds gas exchange, and venoarterial extracorporeal membrane oxygenation provides broader rescue for combined circulatory and respiratory failure. Comparative evidence on timing and configuration remains observational.
Objectives Perioperative right heart failure remains a severe complication after durable left ventricular assist device implantation. Accurate preoperative risk assessment is crucial to identify patients requiring advanced medical or mechanical biventricular support. Existing predictive risk models show limited compara...
M. Sales, R. Zayat, N. Hatam et al.· PLoS ONE· 1 citation
RVFW strain and coupling indexes derived from catheterization and echocardiographic RV strain imaging can aid with the need for an RVAD and RHF risk stratification following LVAD implantation.
Michael Schäfer, S. S. Bakhtiyar, T. Hanff et al.· JACC: Advances· 0 citations
Right heart failure (RHF) remains a major determinant of morbidity and mortality following left ventricular assist device (LVAD) implantation. Right ventricular free wall strain (RVFWS) and global longitudinal strain (RVGLS) have emerged as promising echocardiographic markers, yet their long-term prognostic utility and...
C. Braun, R. Schramm, M. Morshuis et al.· The International Journal of...· 0 citations
BACKGROUND
A subset of patients with advanced heart failure (HF) supported with durable left ventricular assist devices (LVADs) demonstrate significant improvement in left ventricular ejection fraction (LVEF), but the impact of such functional improvement on clinical outcomes is unclear.
METHODS
We analyzed adults in...
E. Maneta, I. Kyriakoulis, C. Kyriakopoulos et al.· Journal of Cardiac Failure· 0 citations
Late right ventricular failure (LRVF)—either de novo beyond the early postoperative period or persistent from earlier phases—remains a major complication after left ventricular assist device (LVAD) implantation and is associated with increased morbidity and mortality compared with resolved early RVF. The right ve...
E. Karapedi, J. G. Bofarull, G. Gallone et al.· European Heart Journal· 0 citations
Durable left ventricular assist devices (LVADs) have become an established therapy for selected patients with advanced heart failure as bridge-to-transplant or destination therapy. Despite major progress in continuous-flow pump design and perioperative care, long-term benefit remains constrained by a recurrent burden o...